A rare case of Gitelman's syndrome presenting with hypocalcemia and osteopenia

Journal of Endocrinological Investigation

Volumn 28, Issue 7, 2005, Pages 464-468

  Nakamura, A ^a   Shimizu, C ^a   Nagai, S ^a   Taniguchi, S ^a   Umetsu, M ^a   Atsumi, T ^a   Yoshioka, N ^a   Ono, Y ^a   Tajima, T ^a   Kubo, M ^b   Koike, T ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY OF EDUCATION   (Japan)

Author keywords

Gitelman's syndrome; Hypocalcemia; Osteopenia; Thiazide sensitive Na Cl cotransporter (TSC) gene

Indexed keywords

ADULT; ANAMNESIS; ARTICLE; BONE DENSITY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE ASSOCIATION; ELECTROLYTE DISTURBANCE; GENETIC ANALYSIS; GITELMAN SYNDROME; HUMAN; HYPERALDOSTERONISM; HYPERRENINEMIA; HYPOCALCEMIA; HYPOCALCIURIA; HYPOKALEMIA; HYPOMAGNESEMIA; KIDNEY FUNCTION TEST; LABORATORY TEST; MALE; OSTEOPENIA; PHYSICAL EXAMINATION; ADOLESCENT; BARTTER SYNDROME; DIFFERENTIAL DIAGNOSIS; GENETICS; METABOLIC BONE DISEASE; MUTATION; SYNDROME;

COTRANSPORTER; DRUG RECEPTOR; SLC12A3 PROTEIN, HUMAN; SODIUM CHLORIDE COTRANSPORTER; THIAZIDE RECEPTOR;

ADOLESCENT; BARTTER SYNDROME; BONE DISEASES, METABOLIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPOCALCEMIA; MALE; MUTATION; RECEPTORS, DRUG; SODIUM CHLORIDE SYMPORTERS; SYMPORTERS; SYNDROME;

EID: 26944484082     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03347229     Document Type: Article

References (25)

1. Gitelman H, Graham J, Welt L. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966, 79: 92-6.
2. Simon DB, Nelson WC, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 1996, 12: 24-30.
3. Bettinelli A, Bianchetti MG, Girardin E, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 1992, 120: 38-43.
4. Stein JH. The pathogenetic spectrum of Bartter's syndrome. Kidney Int 1985, 28: 85-93.
5. Shaer AJ. Inherited Primary Renal Tubular Hypokalemic Alkalosis: A review of Gitalman and Bartter syndromes. Am J Med Sci 2001, 322: 316-32.
6. Turman MA. Concomitant occurrence of Gitelman and Bartter syndromes in the same family? Pediatr Nephrol 1998, 12: 23-5.
7. Simon DB, Lifton RP. The molecular basis of inherited hypokalemic alkalosis: Bartter's and Gitelman's syndromes. Am Physiol Soc 1996, 271: F961-6.
8. Jeck N, Konrad M, Peters M, et al. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res 2000, 48: 754-8.
9. Zelikovic I, Szargel R, Hawash A, et al. A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int 2003, 63: 24-32.
10. Tsukamoto T, Kobayashi T, Kawamoto K, Fukase M, Chihara K. Possible discrimination of Gitelman's syndrome from Bartter's syndrome by renal clearance study: report of two cases. Am J Kidney Dis 1995, 25: 637-41.
11. Tajima T, Kobayashi Y, Abe S, et al. Two novel mutations of thiazide-sensitive Na-Cl cotransporter (TSC) gene in two sporadic Japanese patients with Gitelman's syndrome. Endocr J 2002, 49: 91-6.
12. Bettinelli A, Bianchetti MG, Borella P, et al. Genetic heterogeneity in tubular hypomagnesemia-hypokalemia with hypocalciuria (Gitelman's syndrome). Kidney Int 1995, 47: 547-51.
13. Bettinelli A, Basilico E, Metta MG, Borella P, Jaeger P, Bianchetti MG. Magnesium supplementation in Gitelman's syndrome. Pediatric Nephrol 1999, 13: 311-4.
14. Pantanetti P, Arnaldi G, Balercia G, Mantero F, Giacchetti G. Severe hypomagnesaemia-induced hypocalcaemia in a patient with Gitelman's syndrome. Clin Endocrinol (Oxf) 2002, 56: 413-8.
15. Anast CS, Mohs JM, Kaplan SL, Burns TW. Evidence for parathyroid failure in magnesium deficiency. Science 1972, 177: 606-8.
16. Anast CS, Winnacker JL, Forte LR, Burns TW. Impaired release of parathyroid hormone in magnesium deficiency. J Clin Endocrinol Metab 1976, 42: 707-17.
17. Rude RK, Oldham SB, Sharp CF, Singer FR. Parathyroid hormone secretion in magnesium dificiency. J Clin Endocrinol Metab 1978, 47: 800-6.
18. Bianchetti MG, Bettinelli A, Casez JP, et al. Evidence for disturbed regulation of calciotropic hormone metabolism in Gitelman's syndrome. J Clin Endocrinol Metab 1995, 80: 224-8.
19. Laroche M, Mazieres B. Beneficial effect of a thiazide diuretic on bone mineral density in male osteoporosis with hypercalciuria. Clin Exp Rheumatol 1998, 16: 109-10.
20. Cruz DN, Simon DB, Lifton RP. Inactivating mutations in the Na-Cl co-transporter is associated with high bone density. J Am Soc Nephrol 1999, 10: A3024 (abstract).
21. BonciminoK, McMahon DJ, Addesso V, Bilezikian JP, Shane E. Magnesium deficiency and bone loss after cardiac transplantation. J Bone Miner Res 1999, 14: 295-303.
22. Egami I, Wakai K, Kunimoto H, et al. Association of lifestyle factors with bone mineral density among male university students in Japan. J Epidemiol 2003, 13: 48-55.
23. Rude RK. Magnesium homeostasis. In: Bilezikian JP, Raisz LG, Rodan GA eds. Principles of Bone Biology. New York: Academic Press. 1996, 277-93.
24. Monkawa T, Kurihara I, Kobayashi K, Hayashi M, Saruta T. Novel mutations in thiazide-sensitive Na-Cl cotransporter gene of patients with Gitelman's syndrome. J Am Soc Nephrol 2000, 11: 65-70.
25. Yoo T, Lee S, Yoon K, et al. Identification of novel mutations in Na-Cl cotransporter gene in a Korean patient with atypical Gitelman's syndrome. Am J Kidney Dis 2003, 42: 11-6.